🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07686900
Starting soon Observational

Dynamic Multimodal Delirium Warning After Cardiac Surgery

NCT07686900 · tracked via the Priya Life Science China tracker
Sponsor
Southeast University, China
Phase
Observational
Started
2026-07-06
Last updated
2026-07-08

Condition(s) studied

Postoperative DeliriumCardiac Surgical Procedures

Study summary

After heart surgery, up to half of all patients may develop a state of sudden confusion called postoperative delirium. This condition can lead to longer time on a breathing machine, extended stays in the intensive care unit (ICU), and a slower overall recovery. Currently, doctors have no reliable way to predict delirium early enough to take preventive action. This study aims to build a computer-based early warning system. The system will combine continuous, real-time measurements of brain waves (EEG), the oxygen level in the brain, and heart and blood pressure function. It will also include information about each patient's health status. By analyzing all of these signals together, the model is designed to give an alert 1 to 6 hours before delirium might start, giving the care team a window of time to intervene. The study will take place in the ICU at Zhongda Hospital, Southeast University. Adults between 18 and 80 years old who are admitted to the ICU after heart surgery will be invited to participate. All patients will receive the usual standard of care; the study does not test any new treatment. Participation means the investigators will continuously record the brain, oxygen, and heart signals that are already being monitored, and a researcher will regularly assess the patient's thinking and alertness with a simple bedside check.

Eligibility

Sex
ALL
Min age
15 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Adult patients (18-80 years) admitted to the Department of Critical Care Medicine. 2. Underwent cardiac surgery. 3. Under multimodal monitoring (including EEG, cerebral oximetry, and invasive arterial blood pressure). 4. Signed informed consent. Exclusion Criteria: 1. Pre-existing dementia, history of psychiatric disorders, or long-term use of antipsychotic medications, preventing accurate assessment of delirium. 2. Preoperative severe hepatic or renal insufficiency (Child-Pugh Class C or eGFR \<30 mL/min/1.73 m²). 3. Severe craniocerebral injury, intracranial space-occupying lesion, or history of epilepsy. 4. Inability to obtain continuous EEG or cerebral oximetry signals due to technical reasons (e.g., scalp injury, abnormal probe placement site). 5. Patients expected to die within 24 hours. 6. Patients deemed unsuitable for the study by the investigator.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongda hospital Southeast University Nanjing Jiangsu

More Southeast University, China trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07686900 on ClinicalTrials.gov ↗ ← All trials in China